Learn about our investigation into a potential treatment of dry eye disease. Experience #EyeGate at #ARVO2024. Booth 1838. #DryEye #DiscoveriesBeyondTheOrdinary
Telios Pharma, Inc.
Biotechnology Research
Redwood City, California 1,396 followers
Dedicated scientists, clinicians and innovators, focused on improving the lives of patients with inflammatory diseases.
About us
Telios Pharma is a privately held clinical stage biopharmaceutical company with first-in-class topical and oral BTK inhibitor programs targeting mast cell-mediated inflammation and allergy. Launched in 2019 by proven industry veterans, we have brought together a team of scientists and clinicians with deep therapeutic expertise, and an experienced leadership team. We are passionate, collaborative and dedicated to our mission of improving the lives of patients with inflammatory diseases.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Redwood City, California
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Inflammatory Diseases, Allergy, and Oncology
Locations
-
Primary
Get directions
275 Shoreline Drive
Suite 325
Redwood City, California 94065, US
Employees at Telios Pharma, Inc.
Updates
-
See our vision for the potential future treatment of dry eye disease. Visit #EyeGate at Booth 1838 at #ARVO2024. #DryEye #DiscoveriesBeyondTheOrdinary
-
Telios Pharma, Inc. reposted this
Another exceptional journey with our client Telios Pharma, Inc. at #ARVO2024. Their vision continues to push boundaries. I’m thankful for all my colleagues at The Taylor Group that worked tirelessly to execute this stunning exhibit. A special thank you to Brent Allen, Jason Nopper Cesar Arias and everyone on our creative, fabriaction, audio visual, logistics engineering and installation teams. None of this could be possible without our agency partner Cognition for continuing to be a thoughtful collaborator and supporter. Kudos to all! #eyegate
-
-
Find out how we’re advancing the understanding of dry eye disease. Visit #EyeGate at Booth 1838. #ARVO2024 #DryEye #DiscoveriesBeyondTheOrdinary
-
Peer into the future at #EyeGate. See our latest discoveries in the search for treatment of dry eye disease. Find us at Booth 1838. #ARVO2024. #DryEye #DiscoveriesBeyondTheOrdinary
-
We’re charting new waters. Visit #EyeGate at Booth 1838 to learn more about a potential new therapy for dry eye disease. #ARVO2024 #DryEye #DiscoveriesBeyondTheOrdinary
-
See the latest innovation in the search for a therapy that could potentially restore tear function at #EyeGate. Visit us at Booth 1838. #ARVO2024 #DryEye #DiscoveriesBeyondTheOrdinary
-
Join us in our search for disease modification of dry eye disease. Visit #EyeGate at Booth 1838 to learn more about our science. #ARVO2024 #DryEye #DiscoveriesBeyondTheOrdinary
-
A sea of change is coming in the potential future of dry eye disease. The #EyeGate is opening at #ARVO2024. Find us at Booth 1838. #DryEye #DiscoveriesBeyondTheOrdinary
-
Discover what's on the horizon for dry eye disease at #EyeGate. Visit Booth 1838 at #ARVO2024 to find out more. #DryEye #DiscoveriesBeyondTheOrdinary